A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availability

被引:14
作者
Pandey, Suchitra [1 ,2 ]
Belanger, Geoffrey A. [2 ]
Rajbhandary, Srijana [3 ]
Cohn, Claudia S. [3 ,4 ]
Benjamin, Richard J. [5 ]
Bracey, Arthur W. [6 ]
Katz, Louis M. [7 ]
Menitove, Jay E. [8 ]
Mintz, Paul D. [9 ]
Gammon, Richard R. [10 ]
机构
[1] Stanford Univ, Dept Pathol, Palo Alto, CA USA
[2] Stanford Hlth Care, Med Serv Operat Excellence, Stanford Blood Ctr, Palo Alto, CA USA
[3] AABB, Dept Res, Bethesda, MD USA
[4] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[5] Cerus Corp, Clin Res & Med Affairs, Concord, CA USA
[6] Baylor St Lukes Med Ctr, Dept Pathol, Houston, TX USA
[7] ImpactLife, Med Affairs, Davenport, IA USA
[8] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS USA
[9] Verax Biomed Inc, Med Affairs, Marlborough, MA USA
[10] OneBlood, Med Affairs, Orlando, FL USA
关键词
blood management; platelet inventory; platelet transfusion; transfusion practices (adult); CLINICAL-PRACTICE GUIDELINE;
D O I
10.1111/trf.16561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A survey of US hospitals was conducted to increase our understanding of the current state of platelet (PLT) practice and supply. The survey captures information on transfusion practice and inventory management, including stock levels, outdate rates, ability to return or transfer PLTs, and low dose PLTs. Notably, the survey also elucidates PLT availability challenges and impact to patient care. Study design and methods A 27 question online survey was distributed directly to over 995 US hospitals and indirectly through blood centers to many more between September 27 and October 25, 2019. Descriptive statistics were used for respondent characteristics. Bivariate analysis was performed and correlation coefficients, chi square tests, and p values determined statistical significance of relationships between variables. Results Four hundred and eighty-one hospitals completed the survey of which 21.6%, 53.2%, and 25.2% were characterized as small, medium, and large hospitals, respectively. Some key observations from this survey include: (1) there is an opportunity for greater adherence to evidence-based guidelines; (2) higher outdate rates occur in hospitals stocking less than five PLTs and the ability to return or transfer PLTs lowers outdates; (3) use of low dose apheresis PLTs varies; and (4) decreased PLT availability is commonly reported, especially in hospitals with high usage, and can lead to delays in transfusions or surgeries. Conclusion This survey represents a comprehensive national assessment of inventory management practices and PLT availability challenges in US hospitals. Findings from this survey can be used to guide further research, help shape future guidance for industry, and assist with policy decisions.
引用
收藏
页码:2611 / 2620
页数:10
相关论文
共 29 条
[1]   The argument(s) for lowering the US minimum required content of apheresis platelet components [J].
Benjamin, Richard J. ;
Katz, Louis ;
Gammon, Richard R. ;
Stramer, Susan L. ;
Quinley, Eva ;
Armitage, John ;
Barnes, Linda ;
Benjamin, Richard J. ;
Boraz, Margie ;
Borge, P. Dayand ;
Bracey, Art ;
Cohn, Claudia S. ;
Crawford, Chris ;
Evans, Jill ;
Gammon, Richard ;
Hoiles, Jonathan ;
Katz, Lou ;
Koski, Karen ;
Menitove, Jay ;
Quinley, Eva ;
Schiffer, Charles A. ;
Stramer, Susan ;
Strauss, Donna ;
Stubbs, James R. ;
Waller, Ned ;
Rowe, Kathleen .
TRANSFUSION, 2019, 59 (02) :779-788
[2]   Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients [J].
Butler, Caroline E. ;
Noel, Simon ;
Hibbs, Stephen P. ;
Miles, David ;
Staves, Julie ;
Mohaghegh, Payam ;
Altmann, Paul ;
Curnow, Elinor ;
Murphy, Michael F. .
TRANSFUSION, 2015, 55 (08) :1964-1971
[3]   Evaluation of platelet transfusion triggers in a tertiary-care hospital [J].
Cameron, Bruce ;
Rock, Gail ;
Olberg, Bernard ;
Neurath, Doris .
TRANSFUSION, 2007, 47 (02) :206-211
[4]   Where did platelets go in 2012? A survey of platelet transfusion practice in the North of England [J].
Charlton, A. ;
Wallis, J. ;
Robertson, J. ;
Watson, D. ;
Iqbal, A. ;
Tinegate, H. .
TRANSFUSION MEDICINE, 2014, 24 (04) :213-218
[5]   A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation [J].
Crighton, Gemma L. ;
Estcourt, Lise J. ;
Wood, Erica M. ;
Trivella, Marialena ;
Doree, Carolyn ;
Stanworth, Simon .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09)
[6]   How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service? [J].
Dunbar, Nancy M. ;
Dumont, Larry J. ;
Szczepiorkowski, Zbigniew M. .
TRANSFUSION, 2016, 56 (06) :1262-1266
[7]   Continued decline in blood collection and transfusion in the United States-2015 [J].
Ellingson, Katherine D. ;
Sapiano, Mathew R. P. ;
Haass, Kathryn A. ;
Savinkina, Alexandra A. ;
Baker, Misha L. ;
Chung, Koo-Whang ;
Henry, Richard A. ;
Berger, James J. ;
Kuehnert, Matthew J. ;
Basavaraju, Sridhar V. .
TRANSFUSION, 2017, 57 :1588-1598
[8]   Platelet transfusions in haematology patients: are we using them appropriately? [J].
Estcourt, L. J. ;
Birchall, J. ;
Lowe, D. ;
Grant-Casey, J. ;
Rowley, M. ;
Murphy, M. F. .
VOX SANGUINIS, 2012, 103 (04) :284-293
[9]   Guidelines for the use of platelet transfusions [J].
Estcourt, Lise J. ;
Birchall, Janet ;
Allard, Shubha ;
Bassey, Stephen J. ;
Hersey, Peter ;
Kerr, Jonathan Paul ;
Mumford, Andrew D. ;
Stanworth, Simon J. ;
Tinegate, Hazel .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (03) :365-394
[10]  
FDA guidance for industry, 2020, BACT RISK CONTR STRA